Swiss stocks - Factors to watch on April 20
20/04/2020 06:47
ZURICH/BERLIN, April 20(Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
NOVARTIS NOVN.S
The company said it has reached an agreement with U.S.
regulators to hold a randomized trial of generic malaria drug
hydroxychloroquine against COVID-19 disease in 440 hospitalised
patients. urn:newsml:reuters.com:*:nZ8N2BP003
Seperately, the company has bought U.S. software start-up
Amblyotech to develop digital technology to treat children and
adults with lazy eye. ASN0005G6
MOLECULAR PARTNERS MOLN.S
The Swiss biotechnology company has started an anti-COVID-19
program, hoping to use molecules from its labs to fight the
virus that has sickened more than 2.4 million people worldwide
and killed 165,000. The Schlieren-based company said initial
testing with the Swiss Federal Office for Civil Protection
confirmed "deep neutralization potential". urn:newsml:reuters.com:*:nASN0005G0
MCH GROUP MCHN.S
LVMH Group joined Rolex in exiting the Baselworld event run
by MCH Group, newspaper Tages-Anzeiger reported on Saturday,
adding to troubles of the trade fair company that is nearly 50%
controlled by Basel city, the canton of Basel and Zurich.
Private investor AMG Fondsverwaltung, with 10.55%, said the
company should be broken up, the paper reported. MCHN.S
STADLER RAIL SRAIL.S
The trainmaker's Chairman Peter Spuhler said in an interview
with SonntagsBlick that the company has not asked for state help
during the coronavirus crisis, adding its order books are
well-filled considering the circumstances, and that factories
are running relatively close to capacity, with the exception of
those in Spain and the United States. SRAIL.S
COMPANY STATEMENTS
* ABB ABBN.S Power Products And Systems India Gets 1.65
Billion Indian Rupees ($21.58 million) Order From Indian Oil
Corporation ABBN.S
* Idorsia IDIA.S said it had had positive results in first
phase 3 study of its insomnia treatment daridorexant. IDIA.S
* Zur Rose Group ROSEG.S withdraws its proposal for
creation of additional conditional capital ROSEG.S
* Roche ROG.S said FDA & EMA accept applications for its
Ocrevus multiple sclerosis treatement with a shorter infusion
time. ROG.S
* Meyer Burger MBTN.S published the agenda and proposals
for its ordinary shareholders' meeting 2020. MBTN.S
ANALYSTS' VIEWS
* KUEHNE UND NAGEL INTERNATIONAL KNIN.S : Jefferies Raises
Target Price To CHF 130 From CHF 125
* COSMO PHARMACEUTICALS NV COPN.S : Credit Suisse Cuts
Target Price To CHF 93 From CHF 108
* BARRY CALLEBAUT AG BARN.S : Credit Suisse Cuts Target
Price To CHF2,100 From CHF 2,225
*
ECONOMY
SNB sight deposits due at 0800 GMT.
($1 = 76.4700 Indian rupees)
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))